Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S D Goyal
Bortezomib Administered Pre-Auto-SCT and as Maintenance Therapy Post Transplant for Multiple Myeloma: A Single Institution Phase II Study
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Bortezomib-Based Consolidation or Maintenance Therapy for Multiple Myeloma: A Meta-Analysis
Blood Cancer Journal
Oncology
Hematology
A Potential Role for Auto-Graft Immune Cell Subsets to Influence Post-Transplant Outcomes in Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Single Versus Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma Patients and Role of Second Salvage Transplant: A Single Center Prospective Phase II Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Dose Increased Once-Weekly Bortezomib-Based Combination Therapy for Multiple Myeloma
Oncotarget
Oncology
A Single Autologous Stem Cell Transplant (ASCT) Followed by Two Years of Post-Transplant Therapy in Older Recently Diagnosed Multiple Myeloma (MM) Patients. Safety and Response Results From the Prospective Phase II Trial (NCT01849783)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Clinical Outcomes of Bortezomib-Based Therapy in Taiwanese Patients With Multiple Myeloma: A Nationwide Population-Based Study and a Single-Institute Analysis
PLoS ONE
Multidisciplinary
Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-Sct) With Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Maintenance Therapy With Low Dose Thalidomide, Dexamethasone and Clarithromycin (BLT-D) Following Autologous Transplant (ASCT) for Multiple Myeloma (MM)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Bortezomib for the Treatment of Multiple Myeloma Patients
Health Technology Assessment
Medicine
Health Policy
